button bars forest bayes pooled summary circles
 
DCR

malignant mesothelioma (mMS) - 1st line (L1) malignant mesothelioma (mMS) - 1st line (L1)

malignant mesothelioma (mMS) - 2nd line (L2) malignant mesothelioma (mMS) - 2nd line (L2)

versus placebo
tremelimumab vs. placebo 1 1.39 [0.92; 2.09], 1 RCT, I2=0%
inconclusive result

 

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons